Treatment of monogenic autoinflammatory disorders, an expanding group of hereditary diseases characterized by apparently unprovoked recurrent episodes of inflammation, without high-titre autoantibodies or antigen-specific T cells, has been revolutionized by the discovery that several of these conditions are caused by mutations in proteins involved in the mechanisms of innate immune response, including components of the inflammasome, cytokine receptors, receptor antagonists, and oversecretion of a network of proinflammatory molecules. Aim of this review is to synthesize the current experience and the most recent evidences about the therapeutic approach with biologic drugs in pediatric and adult patients with monogenic autoinflammatory disorders.

Vitale, A., Rigante, D., Lucherini, O.M., Caso, F., Muscari, I., Magnotti, F., et al. (2013). Biological treatments: new weapons in the management of monogenic autoinflammatory disorders. MEDIATORS OF INFLAMMATION, Article n. 939847 [10.1155/2013/939847].

Biological treatments: new weapons in the management of monogenic autoinflammatory disorders.

Vitale A;LUCHERINI, ORSO MARIA;MAGNOTTI, FLORA;Guerrini S;GALEAZZI, MAURO;CANTARINI, LUCA
2013-01-01

Abstract

Treatment of monogenic autoinflammatory disorders, an expanding group of hereditary diseases characterized by apparently unprovoked recurrent episodes of inflammation, without high-titre autoantibodies or antigen-specific T cells, has been revolutionized by the discovery that several of these conditions are caused by mutations in proteins involved in the mechanisms of innate immune response, including components of the inflammasome, cytokine receptors, receptor antagonists, and oversecretion of a network of proinflammatory molecules. Aim of this review is to synthesize the current experience and the most recent evidences about the therapeutic approach with biologic drugs in pediatric and adult patients with monogenic autoinflammatory disorders.
Vitale, A., Rigante, D., Lucherini, O.M., Caso, F., Muscari, I., Magnotti, F., et al. (2013). Biological treatments: new weapons in the management of monogenic autoinflammatory disorders. MEDIATORS OF INFLAMMATION, Article n. 939847 [10.1155/2013/939847].
File in questo prodotto:
File Dimensione Formato  
Biological-treatments-2013-939847.pdf

non disponibili

Tipologia: Post-print
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 1.92 MB
Formato Adobe PDF
1.92 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/46343
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo